Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.389, 2002-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Moxifloxacin cost effective versus ceftriaxone in AECB
Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. :
Access to resources
Recommend
Moxifloxacin superior in AECB?
Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. :
Moxifloxacin equals ceftriaxone + cefuroxime in pneumonia
Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. :
Moxifloxacin IV-to-oral switch proves cost effective in patients with CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 368, 2002-01 ,pp. :
Moxifloxacin IV-to-oral switch proves cost effective in patients with CAP
Inpharma, Vol. 1, Iss. 1343, 2002-01 ,pp. :